You are viewing the site in preview mode

Skip to main content


Figure 1 | BMC Health Services Research

Figure 1

From: Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

Figure 1

Schematic diagram of the markov model. Each thalassemia patient has two treatment options (RI-HSCT and BT-ICT) The Markov model consists of eight health states and patients receiving RI-HSCT can transition through each of these health states whereas BT-ICT patients can be in either alive BT-ICT state or death state. The cycle length is one year with a 99-year time horizon. RI-HSCT: Reduced intensity hematopoietic stem cell transplantation; BT-ICT: Blood transfusion combined with iron chelating therapy.

Back to article page